Trademark: 79141824
Status Date
Sunday, July 30, 2023
Registration Number
4650967
Registration Date
Tuesday, December 9, 2014
Filing Date
Wednesday, July 31, 2013
Published for Opposition
Tuesday, September 23, 2014
Cancellation Date
Monday, July 31, 2023
5 Molecular diagnostic preparations for medical purposes for detecting mycobacterium tuberculosis (MTB) by real-time PCR amplification; molecular diagnostic preparations for medical purposes for simultaneously detecting mycobacterium tuberculosis (MTB) and nontuberculous mycobacteria (NTM) by real-time PCR amplification; molecular diagnostic preparations for medical purposes for identifying mycobacterium tuberculosis(MTB) and a total of 19 kinds of nontuberculous mycobacteria(NTM) and detecting about 100 kinds of nontuberculous mycobacteria(NTM) by analyzing PCR amplification products using a reverse blot hybridization assay (REBA); molecular diagnostic preparations for medical purposes for simultaneously detecting rifampin and isoniazid susceptibilities by analyzing PCR amplification products using a reverse blot hybridization assay (REBA); molecular diagnostic preparations for medical purposes for detecting resistance to fluoroquinolone, kanamycin and streptomycin, which are second-line drugs, by analyzing PCR amplification products using a reverse blot hybridization assay (REBA); molecular diagnostic preparations for medical purposes for simultaneously detecting human paplilloma virus (HPV), the major cause of uterine cervical cancer and a total of 25 kinds of HPV by analyzing PCR amplification products using a reverse blot hybridization assay (REBA); molecular diagnostic preparations for medical purposes for analyzing the rpoB gene region, which shows species-specific diversity, by PCR-restriction fragment length polymorphism analysis (PCR-RFLP-PRA); molecular diagnostic preparations for medical purposes for simultaneously detecting mycobacterium tuberculosis (MTB) and nontuberculous mycobacteria (NTM) by PCR amplification of the RD (Region of Difference) gene region, which present specifically in mycobacterium tuberculosis (MTB), and the rpoB gene region which is present commonly in all mycobacteria, including MTB; molecular diagnostic preparations for medical purposes for detecting mycobacterium and body fluids, which contain a small number of bacteria
10 A fully automatic system related to tuberculosis diagnosis, namely, cytometers for medical diagnostic use, diagnostic apparatus for the detection of tuberculosis; a medical system for real-time gene amplification, namely, synthetic media for use in the augmentation of genes for medical purposes, medical devices for obtaining body fluid samples containing genes
MOLECU TECH
Color is not claimed as a feature of the mark.
Feb 25, 2024
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Feb 25, 2024
Death Of International Registration
Jul 17, 2022
Total Invalidation Processed By The Ib
Jun 23, 2022
Generic Madrid Transaction Sent To Ib
Jun 23, 2022
Generic Madrid Transaction Created
Feb 25, 2022
Total Invalidation Of Reg Ext Protection Created
Jun 25, 2021
Cancelled Section 71
May 22, 2015
Final Decision Transaction Processed By Ib
May 1, 2015
Final Disposition Notice Sent To Ib
May 1, 2015
Final Disposition Processed
Mar 9, 2015
Final Disposition Notice Created, To Be Sent To Ib
Dec 9, 2014
Registered-Principal Register
Sep 23, 2014
Published For Opposition
Sep 3, 2014
Notice Of Publication
Sep 3, 2014
Notice Of Publication
Aug 19, 2014
Law Office Publication Review Completed
Aug 18, 2014
Approved For Pub - Principal Register
Aug 18, 2014
Teas/Email Correspondence Entered
Aug 18, 2014
Correspondence Received In Law Office
Aug 7, 2014
Assigned To Lie
Aug 5, 2014
Teas Response To Office Action Received
Aug 4, 2014
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 4, 2014
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 4, 2014
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 4, 2014
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 1, 2014
Refusal Processed By Ib
Feb 7, 2014
Non-Final Action Mailed - Refusal Sent To Ib
Feb 7, 2014
Refusal Processed By Mpu
Feb 7, 2014
Non-Final Action (Ib Refusal) Prepared For Review
Feb 6, 2014
Non-Final Action Written
Feb 4, 2014
Application Filing Receipt Mailed
Jan 31, 2014
Assigned To Examiner
Jan 31, 2014
New Application Office Supplied Data Entered
Jan 30, 2014
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
